Pharma Pulse 10/8/24: Ensuring Product Labels Are Easily Understood, Medicare Part D Smoothing Program & more

Ensuring That Product Labels Are Easily Understood

Laura Johnson, senior director, sales, life sciences, Loftware, discusses ways to ensure that product labels are easily understood universally.

Medicare Part D Smoothing Program: Impact on Access and Adherence

The discussion explores how Medicare's Part D smoothing program in 2025 might impact chronic lymphocytic leukemia patients’ access to and adherence to Bruton tyrosine kinase inhibitor therapies and how pharmacists can help navigate this new program. The session concludes with closing remarks.

One of the Biggest AI Boomtowns Is Rising in a Tech-Industry Backwater

Blackstone and TikTok’s parent are among those investing in data centers in Malaysia’s Johor, known for palm-oil plantations.

Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer

Stenta will lead B2B commercial growth strategy as the company strengthens its role as the first choice for community pharmacy and health services in the U.S.

Nicholas Saraceno on LinkedIn

Excited to share that in one week's time, I'll be heading down to DC for IntegriChain's Access Insights Conference! Looking forward to catching up with many familiar faces, including William Roth, who happens to pen Pharmaceutical Commerce Magazine's "Commercialization Corner" column. Our pub is also one of the event sponsors, and I'll be there covering sessions and conducting video interviews with the wonderful KOLs that will be sharing the latest trends, strategies, insights, and tactics for data-driven access and commercialization.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs